The TV megamerger that knocked Jimmy Kimmel off the air is illegal, state officials say
Original Report
Eight state attorneys general have filed an antitrust suit against the $6.2 billion Nexstar-Tegna merger, which the Trump administration backed after Nexstar moved to suspend Kimmel’s show.
Glass House Analysis
Corporate decisions reverberate through local communities—a merger might mean headquarters relocating, a restructuring could eliminate jobs, and strategic shifts affect suppliers and service providers in countless towns. Behind quarterly earnings numbers are real employment decisions, investment choices, and community impacts that shape the economic landscape of regions across the country.
The implications extend beyond the immediate news cycle. Every economic development creates ripples that affect employment, prices, and opportunities in ways that may not be immediately visible but are deeply felt. By tracking these connections, we can better understand how the economy truly works—not as an abstract machine, but as a human system shaped by and shaping the lives of millions.
Enjoyed this analysis?
Get the Glass House Briefing every morning—market news that actually makes sense, delivered free to your inbox.
No spam. Unsubscribe anytime.
More Stories
Column: Jensen Huang doesn’t need a new chip. He needs a new moat.
Jensen Huang is building a new moat with open-source AI — not out of generosity, but necessity, our tech columnist writes.
Trump signals DOJ should continue Powell probe, complicating Warsh Fed nom
Powell has accused the DOJ of investigating him in retaliation for his refusal to lower interest rates as much or as quickly as Trump has demanded.
Iran-induced fertilizer shortage threatens Republicans in farm states ahead of midterms
Democrats are vying for competitive seats across farm country in 2026, and fertilizer shortages spurred by the Iran war give them a new affordability angle.
A high dose of Wegovy that helped people lose 21% of their weight in a clinical trial was just approved
Novo Nordisk’s 7.2 mg dose of Wegovy will compete against Lilly’s GLP-1 injection.